VeriMom¿Es dihydroquercetin seguro durante el embarazo?
No harmonised CLP reproductive classifications (no H360/H361) and no CIR or SCCS safety assessment indicating reproductive hazard. Peer‑reviewed literature on taxifolin (dihydroquercetin) reports antioxidant and pharmacologic effects but does not provide evidence of teratogenicity or reproductive toxicity in humans; ECHA entries are registrations/self‑notifications without harmonised reproductive classification. Dermal exposure from cosmetics is expected to be low but measurable based on compound physicochemistry and cosmetic use patterns (PubChem; ECHA registration dossiers; PubMed).
Pregnancy-safe products containing dihydroquercetin
Related ingredients
Frequently asked questions
- ¿Es dihydroquercetin seguro durante el embarazo?
- No harmonised CLP reproductive classifications (no H360/H361) and no CIR or SCCS safety assessment indicating reproductive hazard. Peer‑reviewed literature on taxifolin (dihydroquercetin) reports antioxidant and pharmacologic effects but does not provide evidence of teratogenicity or reproductive toxicity in humans; ECHA entries are registrations/self‑notifications without harmonised reproductive classification. Dermal exposure from cosmetics is expected to be low but measurable based on compound physicochemistry and cosmetic use patterns (PubChem; ECHA registration dossiers; PubMed).
- ¿Es dihydroquercetin seguro durante la lactancia?
- No evidence of reproductive or lactation toxicity or of mechanisms that would specifically target lactation transfer. No harmonised classifications or regulatory warnings for breastfeeding. Systemic exposure from topical use is expected to be low but measurable; transfer into breast milk is not documented in the literature.
- ¿Es dihydroquercetin seguro para la piel del bebé?
- No infant‑specific reproductive or developmental toxicity data identified. Hazard and mechanistic evidence for developmental effects are absent. Exposure score increased for baby skin because infant/young child skin has higher surface‑area‑to‑weight and a less mature barrier, so low/measurable adult dermal absorption is plausibly higher in infants (PubChem; ECHA registration dossiers; PubMed).
- ¿Cómo puntúa VeriMom a dihydroquercetin?
- VeriMom puntúa dihydroquercetin en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a dihydroquercetin en el embarazo?
- Consulta nuestra lista de alternativas seguras a dihydroquercetin según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.